Skip to main content
Caplight Logo









Heligenics, Inc.

Heligenics, Inc.

Private
Las Vegas, NevadaHealthcare & Life Scienceshttps://www.heligenics.com/

Last Round

Grant

Feb 1, 2025

Total Funding Raised

$4.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Heligenics, Inc. is a biotechnology company that provides functional genomics research and drug discovery services using its proprietary GigaAssay™ technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

functional genomicsdrug discoverydrug discovery platformhigh-throughput screeningbiologic drugprecision medicinevariant librarybiosimilarsbiobettersclinical trial stratificationwet-labdrug optimizationbiotech servicesgenomic datade-risking drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Heligenics, Inc. Comparables

Compare Heligenics, Inc. with similar companies based on industry and business-model similarity.

Heligenics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Constantiam Biosciences
86%
Atlas Biotech
83%
Algen Biotechnologies
78%

Heligenics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2025
SeedJun 9, 2022
SeedDec 15, 2020

Key People

Founding team and executive leadership

Martin R. Schiller

Chairman, CEO

Executive Team

Heligenics, Inc. Investors

Notable investors and investment history

Heligenics, Inc. investors
InvestorRounds
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 364% MoM, reaching 1.9K.

  • Jan 6, 2026

    Monthly visitors grew 643% MoM, reaching 3.2K.

Heligenics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Heligenics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Heligenics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersLas Vegas, Nevada
Employee Range7
Year Founded2019
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?